{ "scientist": "\u003cdiv class=\"view-Scientists\"\u003e\n\t\u003cul id=\"scientist-list\"\u003e\n\t\t  \u003cdiv class=\"views-row views-row-1 views-row-odd views-row-first views-row-last\"\u003e\n    \u003cdiv id=\"scientist-detail\"\u003e\n\t\u003cdiv class=\"left\" style=\"width:183px;\"\u003e\n\t\t\u003cimg  class=\"imagefield imagefield-field_doc_image\" width=\"161\" height=\"183\" alt=\"\" src=\"http:\/\/musclepharm.com\/sites\/default\/files\/team_final_layout_16_0.jpg?1341234808\" \/\u003e\t\u003c\/div\u003e\n\t\u003cdiv class=\"right\" style=\"width:600px;\"\u003e\n\t\t\u003ch4 class=\"heavy green\"\u003eJames Sapirestein, PH.D\u003c\/h4\u003e\t\t\u003ca class=\"print-link\" href=\"\/print\/79578\"\u003ePrint\u003c\/a\u003e\n\t\t\u003ch5 class=\"grey heavy\"\u003eStrategic Advisor\u003c\/h5\u003e\t\t\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd style=\"width:130px;\"\u003e\u003cstrong\u003eResponsibilities\u003c\/strong\u003e :\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003eStrategic Advisor.\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMP teammate since\u003c\/strong\u003e :\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003e2010\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eArea of Expertise :\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003eFormer Executive at Bristol-Myers Squibb, where he served as the head of the its International HIV business as well working in their Infectious Disease marketing teams. He launched several products at BMS including Videx EC\u0026reg;, Zerit\u0026reg;,Tequin\u0026reg;, Maxipime\u0026reg; and Cefzil\u0026reg;.\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\t\u003c\/div\u003e\n\u003c\/div\u003e\n  \u003c\/div\u003e\n\t\u003c\/ul\u003e\n\u003c\/div\u003e\n" }